Zevra to Participate at Upcoming Investor Conferences

Core Insights - Zevra Therapeutics, Inc. is focused on developing therapies for rare diseases with limited treatment options, aiming to provide life-changing therapeutics to affected individuals [2]. Company Events - Zevra's executive leadership team will participate in the TD Cowen 45th Annual Health Care Conference on March 5, 2025, at 10:30 a.m. ET, and the 37th Annual ROTH Conference on March 17, 2025, at 1:00 p.m. PT [1][5]. - Management will be available for one-on-one meetings with registered attendees at each conference [1]. Company Overview - Zevra combines science, data, and patient needs to create transformational therapies, overcoming complex drug development challenges [2]. - The company utilizes unique, data-driven development and commercialization strategies to make new therapies available to the rare disease community [2]. Communication Channels - For more information, Zevra can be followed on X (formerly Twitter) and LinkedIn, and additional details are available on their website [3].